deferiprone has been researched along with Pneumonia in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Pneumonia: Infection of the lung often accompanied by inflammation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
An, HS | 1 |
Yoo, JW | 1 |
Jeong, JH | 1 |
Heo, M | 1 |
Hwang, SH | 1 |
Jang, HM | 1 |
Jeong, EA | 1 |
Lee, J | 1 |
Shin, HJ | 1 |
Kim, KE | 1 |
Shin, MC | 1 |
Roh, GS | 1 |
1 other study available for deferiprone and Pneumonia
Article | Year |
---|---|
Lipocalin-2 promotes acute lung inflammation and oxidative stress by enhancing macrophage iron accumulation.
Topics: Acute Lung Injury; Animals; Deferiprone; Inflammation; Iron; Lipocalin-2; Lipopolysaccharides; Lung; | 2023 |